Region of difference 2 contributes to virulence of mycobacterium tuberculosis

Infection and Immunity

Volumn 79, Issue 1, 2011, Pages 59-66

  Kozak, Robert A ^a   Alexander, David C ^a   Liao, Reiling ^b   Sherman, David R ^b   Behr, Marcel A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; GENETIC COMPLEMENTATION; HISTOPATHOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; LUNG; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGION OF DIFFERENCE 2 GENE; SPLEEN; SURVIVAL; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, BACTERIAL; HOMEODOMAIN PROTEINS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; VIRULENCE;

EID: 78650865730     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00824-10     Document Type: Article

References (42)

1. Andersen, P., D. Askgaard, L. Ljungqvist, M. W. Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 59:1558-1563
2. Arcus, V. L., P. B. Rainey, and S. J. Turner. 2005. The PIN-domain toxin-antitoxin array in mycobacteria. Trends Microbiol. 13:360-365.
3. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523.
4. Casanova, J. L., S. Blanche, J. F. Emile, E. Jouanguy, S. Lamhamedi, F. Altare, J. L. Stephan, F. Bernaudin, P. Bordigoni, D. Turck, A. Lachaux, M. Albertini, A. Bourrillon, J. P. Dommergues, M. A. Pocidalo, F. Le Deist, J. L. Gaillard, C. Griscelli, and A. Fischer. 1996. Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics 98:774-778.
5. Casanova, J. L., E. Jouanguy, S. Lamhamedi, S. Blanche, and A. Fischer. 1995. Immunological conditions of children with BCG disseminated infection. Lancet 346:581.
6. Charlet, D., S. Mostowy, D. Alexander, L. Sit, H. G. Wiker, and M. A. Behr. 2005. Reduced expression of antigenic proteins MPB70 and MPB83 in My-cobacterium bovis BCG strains due to a start codon mutation in sigK. Mol. Microbiol. 56:1302-1313.
7. Chen, J. M., D. C. Alexander, M. A. Behr, and J. Liu. 2003. Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect. Immun. 71:708-716.
8. Divangahi, M., M. Chen, H. Gan, D. Desjardins, T. T. Hickman, D. M. Lee, S. Fortune, S. M. Behar, and H. G. Remold. 2009. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10:899-906.
9. Divangahi, M., S. Mostowy, F. Coulombe, R. Kozak, L. Guillot, F. Veyrier, K. S. Kobayashi, R. A. Flavell, P. Gros, and M. A. Behr. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181: 7157-7165.
10. Freeman, S., F. A. Post, L. G. Bekker, R. Harbacheuski, L. M. Steyn, B. Ryffel, N. D. Connell, B. N. Kreiswirth, and G. Kaplan. 2006. Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J. Interferon Cytokine Res. 26: 27-33.
11. Gordon, S. V., B. Heym, J. Parkhill, B. Barrell, and S. T. Cole. 1999. New insertion sequences and a novel repeated sequence in the genome of My-cobacterium tuberculosis H37Rv. Microbiology 145:881-892.
12. Grover, A., M. F. Ahmed, I. Verma, P. Sharma, and G. K. Khuller. 2006. Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model. Protein Expr. Purif 48:274-280.
13. Harboe, M., S. Nagai, M. E. Patarroyo, M. L. Torres, C. Ramirez, and N. Cruz. 1986. Properties of proteins MPB64, MPB70, and MPB80 of Myco-bacterium bovis BCG. Infect. Immun. 52:293-302.
14. Jensen, K. A. 1946. Practice of the Calmette vaccination. Acta Tuberc. Scand. 20:1-45.
15. Keane, J., H. G. Remold, and H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016-2020.
16. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
17. Leung, A. S., V. Tran, Z. Wu, X. Yu, D. C. Alexander, G. F. Gao, B. Zhu, and J. Liu. 2008. Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC Genomics 9:413.
18. Lewis, K. N., R. Liao, K. M. Guinn, M. J. Hickey, S. Smith, M. A. Behr, and D. R. Sherman. 2003. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J. Infect. Dis. 187:117-123.
19. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bo-vis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
20. Mitchell, J. W., N. Baik, F. J. Castellino, and L. A. Miles. 2006. Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood 107:4383-4390.
21. Mostowy, S., A. G. Tsolaki, P. M. Small, and M. A. Behr. 2003. The in vitro evolution of BCG vaccines. Vaccine 21:4270-4274.
22. Mustafa, T., H. G. Wiker, O. Morkve, and L. Sviland. 2007. Reduced apop-tosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response. Clin. Exp. Immunol. 150:105-113.
23. Nash, K. A. 2003. Intrinsic macrolide resistance in Mycobacterium smegma-tis is conferred by a novel erm gene, erm(38). Antimicrob. Agents Che-mother. 47:3053-3060.
24. Pym, A. S., P. Brodin, R. Brosch, M. Huerre, and S. T. Cole. 2002. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Myco-bacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46:709-717.
25. Pym, A. S., P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K. E. Griffiths, G. Marchal, C. Leclerc, and S. T. Cole. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9:533-539.
26. Raghavan, S., P. Manzanillo, K. Chan, C. Dovey, and J. S. Cox. 2008. Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 454:717-721.
27. Ramage, H. R., L. E. Connolly, and J. S. Cox. 2009. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 5:e1000767.
28. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. Kaplan, and C. E. Barry III. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87.
29. Riendeau, C. J., and H. Kornfeld. 2003. THP-1 cell apoptosis in response to Mycobacterial infection. Infect. Immun. 71:254-259.
30. Roach, D. R., A. G. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168:4620-4627.
31. Rojas, M., M. Olivier, P. Gros, L. F. Barrera, and L. F. Garcia. 1999. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent My-cobacterium tuberculosis in murine macrophages. J. Immunol. 162:6122-6131.
32. Rustad, T. R., M. I. Harrell, R. Liao, and D. R. Sherman. 2008. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 3:e1502.
33. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704.
34. Sherman, D. R., K. M. Guinn, M. J. Hickey, S. K. Mathur, K. L. Zakel, and S. Smith. 2004. Mycobacterium tuberculosis H37Rv: delta RD1 is more virulent than M. bovis bacille Calmette-Guerin in long-term murine infection. J. Infect. Dis. 190:123-126.
35. Spira, A., J. D. Carroll, G. Liu, Z. Aziz, V. Shah, H. Kornfeld, and J. Keane. 2003. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am. J. Respir. Cell Mol. Biol. 29:545-551.
36. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, et al. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
37. Talbot, E. A., M. D. Perkins, S. F. Silva, and R. Frothingham. 1997. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin. Infect. Dis. 24:1139-1146.
38. Tsolaki, A. G., A. E. Hirsh, K. DeRiemer, J. A. Enciso, M. Z. Wong, M. Hannan, Y. O. Goguet de la Salmoniere, K. Aman, M. Kato-Maeda, and P. M. Small. 2004. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. U.S.A. 101:4865-4870.
39. Veyrier, F., B. Said-Salim, and M. A. Behr. 2008. Evolution of the mycobac-terial SigK regulon. J. Bacteriol. 190:1891-1899.
40. Wang, Z., B. M. Potter, A. M. Gray, K. A. Sacksteder, B. V. Geisbrecht, and J. H. Laity. 2007. The solution structure of antigen MPT64 from Mycobac-terium tuberculosis defines a new family of beta-grasp proteins. J. Mol. Biol. 366:375-381.
41. Xolalpa, W., A. J. Vallecillo, M. Lara, G. Mendoza-Hernandez, M. Comini, R. Spallek, M. Singh, and C. Espitia. 2007. Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis. Proteomics 7:3332-3341.
42. Zeyland, J., and E. Piasecka-Zeyland. 1936. Sur la vitalite du BCG dans l'organisme vaccine. Ann. Institut Pasteur 56:46-51.